Evidence map›Paper›PMID 34237280›Full record

ArticleAmerican journal of human genetics2021

Optical genome mapping enables constitutional chromosomal aberration detection.

Tuomo Mantere, Kornelia Neveling, Céline Pebrel-Richard, Marion Benoist, Guillaume van der Zande, Ellen Kater-Baats, Imane Baatout, Ronald van Beek, Tony Yammine, Michiel Oorsprong and 13 more

Registry-linked trialOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in American journal of human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05295277 (Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort), which is not on this map. Cited by 162 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed, 1 pooled it
28.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05295277 unknown statusnot on this map

Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort

TypeobservationalSponsorBionano GenomicsRan2020 to 2024Enrolled1,000ConditionsDevelopmental Disability, Intellectual Disability, Autism Spectrum Disorder, Congenital AnomalyArmsStandard of care genetic testing group
3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 1 synthesis or guideline pooled it, 244 citations in OpenAlex.

  1. Genes · 2026
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Ring chromosomes uncovered by optical genome mapping: impact of telomeric-associated regions and reference genome selection on structural variant interpretation.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Detection of a complex chromosomal rearrangement in a novel mouse mutant by optical genome mapping.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  12. Article
  13. Article
  14. The entireAntimicrobial agents and chemotherapy · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 4 countries.

Tuomo MantereDepartment of Human Genetics, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands; Radboud Institute of Medical Life Sciences, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit and Biocenter Oulu, University of Oulu, 90220 Oulu, Finland.
Kornelia NevelingDepartment of Human Genetics, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands; Radboud Institute of Health Sciences, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands.
Céline Pebrel-RichardDepartment of Chromosomal and Molecular Genetics, University Hospital of Clermont-Ferrand, 63003 Clermont-Ferrand, France.
Marion BenoistDepartment of Cytogenetics, APHP.centre - Université de Paris, Hôpital Cochin, 75014 Paris, France.
Guillaume van der ZandeDepartment of Human Genetics, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands.
Ellen Kater-BaatsDepartment of Human Genetics, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands.
Imane BaatoutDepartment of Cytogenetics, APHP.centre - Université de Paris, Hôpital Cochin, 75014 Paris, France.
Ronald van BeekDepartment of Human Genetics, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands.
Tony YammineInstitut Neuromyogène, CNRS UMR 5310, INSERM U1217, Lyon 1 University, 69008 Lyon, France; Unit of Medical Genetics, Saint-Joseph University, 1107 2180 Beyrouth, Lebanon.
Michiel OorsprongDepartment of Human Genetics, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands.
Faten HsoumiDepartment of Cytogenetics, APHP.centre - Université de Paris, Hôpital Cochin, 75014 Paris, France.
Daniel Olde-WeghuisDepartment of Human Genetics, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands.
Wed MajdaliDepartment of Cytogenetics, APHP.centre - Université de Paris, Hôpital Cochin, 75014 Paris, France.
Susan VermeulenDepartment of Human Genetics, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands.
Marc PauperDepartment of Human Genetics, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands.
Aziza LebbarDepartment of Cytogenetics, APHP.centre - Université de Paris, Hôpital Cochin, 75014 Paris, France.
Marian Stevens-KroefDepartment of Human Genetics, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands.
Damien SanlavilleInstitut Neuromyogène, CNRS UMR 5310, INSERM U1217, Lyon 1 University, 69008 Lyon, France; Department of Genetics, Hospices Civils de Lyon, 69677 Bron, France.
Jean Michel DupontDepartment of Cytogenetics, APHP.centre - Université de Paris, Hôpital Cochin, 75014 Paris, France; Université de Paris, Cochin Institute U1016, INSERM, 75014 Paris, France.
Dominique SmeetsDepartment of Human Genetics, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands.
Alexander HoischenDepartment of Human Genetics, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands; Radboud Institute of Medical Life Sciences, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6500HB Nijmegen, the Netherlands. Electronic address: alexander.hoischen@radboudumc.nl.
Caroline Schluth-BolardInstitut Neuromyogène, CNRS UMR 5310, INSERM U1217, Lyon 1 University, 69008 Lyon, France; Department of Genetics, Hospices Civils de Lyon, 69677 Bron, France.
Laïla El KhattabiDepartment of Cytogenetics, APHP.centre - Université de Paris, Hôpital Cochin, 75014 Paris, France; Université de Paris, Cochin Institute U1016, INSERM, 75014 Paris, France. Electronic address: laila.el-khattabi@aphp.fr.
Radboud University Medical Center · NLRadboud University Nijmegen · NLAssistance Publique – Hôpitaux de Paris · FRInserm · FRCentre National de la Recherche Scientifique · FRHôpital Cochin · FRInstitut NeuroMyoGène · FRRadboud Institute for Molecular Life Sciences · NLUniversité Claude Bernard Lyon 1 · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromosomal aberrations including structural variations (SVs) are a major cause of human genetic diseases. Their detection in clinical routine still relies on standard cytogenetics. Drawbacks of these tests are a very low resolution (karyotyping) and the inability to detect balanced SVs or indicate the genomic localization and orientation of duplicated segments or insertions (copy number variant [CNV] microarrays). Here, we investigated the ability of optical genome mapping (OGM) to detect known constitutional chromosomal aberrations. Ultra-high-molecular-weight DNA was isolated from 85 blood or cultured cells and processed via OGM. A de novo genome assembly was performed followed by structural variant and CNV calling and annotation, and results were compared to known aberrations from standard-of-care tests (karyotype, FISH, and/or CNV microarray). In total, we analyzed 99 chromosomal aberrations, including seven aneuploidies, 19 deletions, 20 duplications, 34 translocations, six inversions, two insertions, six isochromosomes, one ring chromosome, and four complex rearrangements. Several of these variants encompass complex regions of the human genome involved in repeat-mediated microdeletion/microduplication syndromes. High-resolution OGM reached 100% concordance compared to standard assays for all aberrations with non-centromeric breakpoints. This proof-of-principle study demonstrates the ability of OGM to detect nearly all types of chromosomal aberrations. We also suggest suited filtering strategies to prioritize clinically relevant aberrations and discuss future improvements. These results highlight the potential for OGM to provide a cost-effective and easy-to-use alternative that would allow comprehensive detection of chromosomal aberrations and structural variants, which could give rise to an era of "next-generation cytogenetics."

Indexed as

Chromosome AberrationsDNA Copy Number VariationsGenome, HumanChromosome DisordersChromosome MappingCytogenetic AnalysisHumansKaryotypingMicroarray Analysisbreakpoint characterizationchromosomal aberrationCNV microarrayconstitutional aberrationscytogeneticsFISHkaryotypingOGMoptical genome mappingstructural variants

Identifiers

PMID34237280
PMCPMC8387289
OpenAlexW3178401452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.